AU560235B2 - Preparation of steroid carboxylic acid esters - Google Patents

Preparation of steroid carboxylic acid esters

Info

Publication number
AU560235B2
AU560235B2 AU28832/84A AU2883284A AU560235B2 AU 560235 B2 AU560235 B2 AU 560235B2 AU 28832/84 A AU28832/84 A AU 28832/84A AU 2883284 A AU2883284 A AU 2883284A AU 560235 B2 AU560235 B2 AU 560235B2
Authority
AU
Australia
Prior art keywords
preparation
carboxylic acid
acid esters
steroid carboxylic
steroid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU28832/84A
Other languages
English (en)
Other versions
AU2883284A (en
Inventor
Sten Krister Kristensson
Karl-Erik Lundvall
Anders Robert Stamvik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Leo AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo AB filed Critical Leo AB
Publication of AU2883284A publication Critical patent/AU2883284A/en
Application granted granted Critical
Publication of AU560235B2 publication Critical patent/AU560235B2/en
Assigned to PHARMACIA AB reassignment PHARMACIA AB Alteration of Name(s) in Register under S187 Assignors: AKTIEBOLAGET LEO
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074—Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Amplifiers (AREA)
AU28832/84A 1983-05-30 1984-05-30 Preparation of steroid carboxylic acid esters Expired AU560235B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8303031 1983-05-30
SE8303031A SE8303031D0 (sv) 1983-05-30 1983-05-30 Improved steroid esters preparation

Publications (2)

Publication Number Publication Date
AU2883284A AU2883284A (en) 1984-12-06
AU560235B2 true AU560235B2 (en) 1987-04-02

Family

ID=20351375

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28832/84A Expired AU560235B2 (en) 1983-05-30 1984-05-30 Preparation of steroid carboxylic acid esters

Country Status (18)

Country Link
US (1) US4537722A (enExample)
EP (1) EP0127829B1 (enExample)
JP (1) JPS6041696A (enExample)
AT (1) ATE32603T1 (enExample)
AU (1) AU560235B2 (enExample)
CA (1) CA1211430A (enExample)
DE (1) DE3469440D1 (enExample)
DK (1) DK162100C (enExample)
ES (1) ES8503008A1 (enExample)
FI (1) FI80710C (enExample)
GR (1) GR82048B (enExample)
HU (1) HU198217B (enExample)
IE (1) IE57425B1 (enExample)
IL (1) IL71870A (enExample)
NZ (1) NZ208174A (enExample)
PT (1) PT78661B (enExample)
SE (1) SE8303031D0 (enExample)
ZA (1) ZA843946B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776923A (en) * 1993-01-19 1998-07-07 Endorecherche, Inc. Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone
CN1100541C (zh) * 1993-01-19 2003-02-05 恩多研究公司 脱氢表雄酮的治疗用途和传送系统
DE4433374A1 (de) * 1994-09-20 1996-03-21 Hoechst Ag 17-Desoxi-corticosteroid-21-/O/-Carbonsäure- ester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
US5892068A (en) * 1998-08-25 1999-04-06 Mcneil-Ppc, Inc. Preparation of sterol and stanol-esters
US6087522A (en) * 1999-10-12 2000-07-11 Fan Tech Corporation Silicone lanolin esters
EP1709062B9 (en) 2004-01-16 2013-02-13 Cedarburg Pharmaceuticals, Inc. Exemestane and its intermediates and methods of making the same
JP5579074B2 (ja) * 2008-11-10 2014-08-27 株式会社ブリヂストン 変性天然ゴム及びその製造方法、並びにそれを用いたゴム組成物及びタイヤ

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1050883A (enExample) *
DE1958954C3 (de) * 1969-11-24 1978-11-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Veresterung von Alkoholen
US3678082A (en) * 1970-07-30 1972-07-18 Searle & Co Esterification of 17-hydroxy steroids
GB1558472A (en) * 1976-01-22 1980-01-03 Leo Ab 17-esters of 17- hydroxy gestogens
GB1565680A (en) * 1976-12-31 1980-04-23 Leo Ab Method for the preparation of carboxylic acid esters

Also Published As

Publication number Publication date
ZA843946B (en) 1984-12-24
NZ208174A (en) 1987-04-30
IE57425B1 (en) 1992-09-09
DK162100C (da) 1992-02-24
EP0127829B1 (en) 1988-02-24
AU2883284A (en) 1984-12-06
US4537722A (en) 1985-08-27
EP0127829A3 (en) 1985-08-07
DK162100B (da) 1991-09-16
ES532905A0 (es) 1985-02-01
SE8303031D0 (sv) 1983-05-30
EP0127829A2 (en) 1984-12-12
DK265484D0 (da) 1984-05-29
IE841192L (en) 1984-11-30
CA1211430A (en) 1986-09-16
GR82048B (enExample) 1984-12-12
HU198217B (en) 1989-08-28
JPS6041696A (ja) 1985-03-05
PT78661A (en) 1984-06-01
FI842164A0 (fi) 1984-05-30
HUT34222A (en) 1985-02-28
IL71870A (en) 1986-10-31
JPH0369360B2 (enExample) 1991-10-31
DE3469440D1 (en) 1988-03-31
FI80710B (fi) 1990-03-30
ES8503008A1 (es) 1985-02-01
ATE32603T1 (de) 1988-03-15
IL71870A0 (en) 1984-09-30
FI842164L (fi) 1984-12-01
PT78661B (en) 1986-06-26
DK265484A (da) 1984-12-01
FI80710C (fi) 1990-07-10

Similar Documents

Publication Publication Date Title
AU571225B2 (en) Retro-inverso analogues of the bradykinin potentiating peptide bpp 5a
DE69432109D1 (de) Synthetische, vielfache tandemwiederholungen des mucinpeptides und seiner derivate und deren verwendung
ATE209038T1 (de) Pharmazeutisches präparat, das heparin, heparinfragmente oder -derivate in kombination mit glycerinestern enthält
IE42692L (en) Oestrogenic compositions
IE45390L (en) Anti-caries composition
AU6844790A (en) Novel a-nor-steriod-3-carboxylic acid derivatives
SE9301172D0 (sv) Foerfarande foer framstaellning av en peptidalkohol
ZA822887B (en) Process for producing ethylene glycol and/or glycolic acid ester,catalyst composition used therefor,and process for production thereof
ES8502417A1 (es) "un procedimiento para obtener de orina una fraccion que contiene un ingrediente antineoplastico de naturaleza peptidica".
AU560235B2 (en) Preparation of steroid carboxylic acid esters
EP0884306A3 (en) Synthesis of amido acids from Carboxylic acids and lactams
EP0642507A4 (en) Catalytic antibodies against cocaine and methods of using and producing same.
AU7242687A (en) Nucleic acid and methods for the synthesis of novel DAF compositions
AU4554396A (en) Superior thrombomodulin analogs for pharmaceutical use
EE9900310A (et) Polüreaktsiooniprodukte sisaldav materjal ja selle valmistamise meetod
IE46290L (en) Improved method of preparing carboxylic acid esters
ATE203665T1 (de) Stabilisierte pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung
EP0232107A3 (en) Human lymphotoxin polypeptide derivative
Rabiet et al. Purification and partial characterization of a new variant of human prothrombin: prothrombin Metz
JPS63258896A (ja) 修飾インタ−ロイキン−２
ATE46692T1 (de) (6,11-dihydro-11-oxodibenz(b,e>oxepinyl)pentaans|uren und derivate, verfahren und zwischenprodukte zu deren herstellung und deren verwendung als arzneimittel.
TH16228A (th) กรรมวิธีสำหรับการเตรียมของกรดคาร์บอกซิลิกหรือเอสเทอร์ที่สมนัยกันโดยมีตัวเร่งปฏิกิริยาที่มีพื้นฐานเป็นอิริเดียมอยู่ด้วย
IE872278L (en) Process and intermediates for n-(s-3-alkylheptanoyl)-d-¹-gamma-glutamyl-glycyl-d-alanine.
CA2051397A1 (en) Oxidative preparation of 3,5-secoandrost-5-one-3,17.beta.-dioic acid
AU3620397A (en) Process for preparation of d-proline derivatives by means of micro-organisms